NW16 is an orally active inhibitor for STAT3 with Kd of 11.0 µM. NW16 arrests the cell cycle at S phase, induces apoptosis in HCT116, and inhibits the proliferation of cancer cell HCT116, A549, and B16 with IC50s of 0.28, 1.22, and 9.86 µM, respectively. NW16 induces the production of ROS, inhibits the PI3K/AKT signaling pathway, and thus exhibits antitumor efficacy in mouse model[1].
Molekulargewicht:
336.30
Formel:
C18H12N2O5
Target-Kategorie:
Apoptosis,Reactive Oxygen Species (ROS),STAT
Anwendungsbeschreibung:
MCE Product type: Reference compound
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
